MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Dollar
Positive Cash Flow Breakdown
Addition of partnership shares
Net income (loss)
(increase) decrease in dividends...
Others
Negative Cash Flow Breakdown
Redemption of partnership shares
Change in unrealized (gain) loss...
Increase (decrease) in payable d...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss)
15,388,088
109,699,058
3,703,605
-55,875,975
Change in unrealized (gain) loss on open commodity futures contracts
25,624,373
-18,973,761
-157,399
20,961,333
(increase) decrease in prepaid registration fees
-
-
0
0
Change in unrealized (gain) loss on open swap contracts
-14
43
274
-
Change in unrealized (gain) loss on open otc commodity swap contracts
-
-
-
1,235
(increase) decrease in receivable from due from broker
-
802,981
-2,793,974
-26,442,996
(increase) decrease in dividends receivable
-209,476
-91,751
-24,721
364,822
(increase) decrease in interest receivable
67,124
-259,134
-183,516
377,980
(increase) decrease in prepaid insurance
-29,706
51,754
-101,485
-1,103
(increase) decrease in etf transaction fees receivable
0
-3,650
-
2,000
Increase (decrease) in payable due to broker
-191,370
-25,282,108
27,002,561
-7,837,183
Increase (decrease) in general partner management fees payable
-23,963
-48,854
-2,730
110,616
Increase (decrease) in professional fees payable
129,071
-621,588
489,401
222,992
Increase (decrease) in brokerage commissions payable
-
-
-171,877
-
Increase (decrease) in directors' fees payable
-4,137
-7,670
2,039
3,196
Increase (decrease) in license fees payable
-747
-3,778
3,438
4,882
Increase decrease in registration fees payable
-
-
0
0
Net cash provided by (used in) operating activities
-9,352,378
102,204,578
34,291,469
-87,870,689
Addition of partnership shares
169,504,601
740,920,602
391,998,130
451,013,109
Redemption of partnership shares
216,873,870
950,400,872
494,185,156
105,019,825
Net cash provided by (used in) financing activities
-47,369,269
-209,480,270
-102,187,026
345,993,284
Net increase (decrease) in cash and cash equivalents
-56,721,647
-107,275,692
-67,895,557
258,122,595
Total cash, cash equivalents and equity in trading accounts, beginning of period
469,574,977
576,850,669
644,746,226
677,126,774
Total cash, cash equivalents and equity in trading accounts, end of period
412,853,330
469,574,977
576,850,669
644,746,226
Cash and cash equivalents
287,602,465
-
-
-
Cash and cash equivalents
125,250,865
-
-
-
Total cash, cash equivalents and equity in trading accounts
412,853,330
469,574,977
576,850,669
-
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net increase
(decrease) in cash and cash...
-$56,721,647
(80.47%↑ Y/Y)
Addition of partnership
shares
$169,504,601
(-74.51%↓ Y/Y)
Net income (loss)
$15,388,088
(-82.19%↓ Y/Y)
something is missing
$802,981
(increase) decrease in
dividends receivable
-$209,476
(79.76%↑ Y/Y)
Increase (decrease) in
professional fees payable
$129,071
(124.53%↑ Y/Y)
(increase) decrease in
prepaid insurance
-$29,706
(-121.24%↓ Y/Y)
Change in unrealized
(gain) loss on open swap...
-$14
(-101.37%↓ Y/Y)
Net cash provided by
(used in) financing...
-$47,369,269
(89.95%↑ Y/Y)
Net cash provided by
(used in) operating...
-$9,352,378
(-105.17%↓ Y/Y)
Canceled cashflow
$169,504,601
Canceled cashflow
$16,559,336
Redemption of partnership
shares
$216,873,870
(-80.91%↓ Y/Y)
Change in unrealized
(gain) loss on open...
$25,624,373
(125.48%↑ Y/Y)
Increase (decrease) in
payable due to broker
-$191,370
(99.47%↑ Y/Y)
(increase) decrease in
interest receivable
$67,124
(109.49%↑ Y/Y)
Increase (decrease) in
general partner...
-$23,963
(89.69%↑ Y/Y)
Increase (decrease) in
directors' fees payable
-$4,137
(56.11%↑ Y/Y)
Increase (decrease) in
license fees payable
-$747
(95.70%↑ Y/Y)
Buy us a coffee
United States Natural Gas Fund, LP (UNG)
United States Natural Gas Fund, LP (UNG)